Pharmidex is honored to attend the Society for Medicines Research meeting:
December 4, 2024
"Recent Trends in Medicinal Chemistry and Enabling Technologies"
📅 Thursday, 5 December 2024
📍 Burlington House, Piccadilly, London, W1J 0BQ, UK
👉 https://lnkd.in/gi3anrpG
We are excited to share that our Business Development Manager,
Janette Dalay Robertson, will represent
Pharmidex at this prestigious event.
Janette looks forward to engaging with attendees to explore and foster commercial synergies, advancing shared goals and collaboration between your companies, institutions, and
Pharmidex.
If you're attending, be sure to connect with Janette for a discussion about how we can work together to achieve innovative breakthroughs! 🌟
#Pharmidex #MedicinalChemistry #Collaboration #Innovation #Chemistry #Chemicalbiology #Medicinesresearch #Peptides #Oligonucleotides #Drugdiscovery #AI #TPD #RoyalSocietyofChemistry
We’re excited to welcome Grace Horne as our new Bioanalytical Scientist! 🎉 Grace brings great enthusiasm and passion for science, and we’re confident she’ll make a fantastic contribution to our team. Welcome aboard, Grace, we’re thrilled to have you with us! 💜
We’re pleased to share that Janette Dalay Robertson , Business Development Manager at Pharmidex , will attend the DDW Turning Science into Business Symposium 2025 on Tuesday, 4th November, at the The Francis Crick Institute , London. Janette looks forward to connecting with industry leaders and exploring new collaboration opportunities.
We’re delighted to announce that Pharmidex will present our poster "Driving breakthroughs in Parkinson’s & neurodegeneration research” at the upcoming RSC BMCS meeting. With over 23 years of CNS expertise, we support biopharma partners in developing new therapies for Parkinson’s disease and tauopathies, through: 🔹 Parkinson’s & neurodegeneration models 🔹 Transgenic CNS lines (incl. 5xFAD) 🔹 Biomarker & BBB penetration studies Join us in Cambridge to explore how our GLP-accredited CNS platforms accelerate discovery and development.
